Titan Pharmaceuticals, Inc.

Navigate Titan Pharmaceuticals, Inc.

  • Home
  • About
    • Overview
    • Who We Are
    • IP Portfolio
    • Management Team
    • Board of Directors
    • Careers
  • Technology
  • Pipeline
    • Kappa Opioid Receptor Agonist
    • Nalmefene Implant
  • News
    • Overview
    • Press Releases
    • Events
    • Presentations
    • In the News
    • Publications
    • Posters
    • Media Resources
  • Investors
    • Overview
    • News / Events
    • Company Information
    • Stock Data
    • SEC Filings
    • Corporate Governance
  • Contact
  • Search
  • Twitter

Press Releases

  • Home
  • News
  • Press Releases
News

Navigate News

  • Overview
  • Press Releases
  • Events
  • Presentations
  • In the News
  • Publications
  • Posters
  • Media Resources

Press Releases

  • All News
  • 2022
  • 2021
  • 2020
  • 2019
  • 2018
  • 2017
  • 2016
  • 2015
  • 2014
  • 2013
  • 2012
  • 2011
  • 2010
  • 2009

Titan Pharmaceuticals Announces Rigorous Sensitivity Analyses Confirm Effectiveness of Probuphine(R) for Opioid Dependence

June 15, 2016

Titan Pharmaceuticals Receives $15 Million Milestone Payment Following FDA Approval of Probuphine(R)

June 13, 2016

Titan Pharmaceuticals Announces FDA Approval of Probuphine(R) for the Treatment of Opioid Dependence

May 26, 2016

Titan Pharmaceuticals Reports First Quarter 2016 Financial Results

May 10, 2016

Titan Pharmaceuticals Schedules Conference Call to Review First Quarter 2016 Financial Results

May 4, 2016

Titan Pharmaceuticals Announces Presentation of Probuphine Phase 3 Data at American Society of Addiction Medicine Annual Conference

April 15, 2016

Titan Pharmaceuticals Reports Full Year and Fourth Quarter 2015 Financial Results

March 15, 2016

Titan Pharmaceuticals to Present at 28th Annual ROTH Conference

March 8, 2016

Titan Pharmaceuticals Schedules Conference Call to Review Fourth Quarter and Full Year 2015 Financial Results

March 8, 2016

Titan Pharmaceuticals Receives Feedback From FDA on Ropinirole Implant Development Program for Parkinson's Disease

March 7, 2016

  • « Previous
  • 1...
  • 7
  • 8
  • 9
  • 10
  • 11
  • 12
  • 13
  • 14
  • 15
  • 16
  • ...24
  • Next »
© 2023 Titan Pharmaceuticals, Inc. All Rights Reserved.
Privacy Policy Titan FCOI Policy Disclaimer Sitemap Twitter